Autolus Therapeutics plc (FRA:6A3A)

Autolus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	171.41	104.13	227.38	239.57	382.44	310.34
Short-Term Investments	30.22	196.58	360.64	-	-	-
Cash & Short-Term Investments	201.63	300.71	588.02	239.57	382.44	310.34
Cash Growth	-55.62%	-48.86%	145.45%	-37.36%	23.23%	102.44%
Accounts Receivable	44.91	24.55	0.95	1.05	0.15	0.07
Other Receivables	32.65	51.24	47.3	23.5	28.82	26.18
Receivables	77.56	75.79	48.24	24.54	28.98	26.25
Inventory	33.43	33.21	4.14	-	-	-
Prepaid Expenses	19.34	21.28	15.21	8.64	12.34	8.71
Restricted Cash	1.5	1.5	1.43	0.77	0.33	0.34
Other Current Assets	2.64	3.43	3.89	1.79	1.7	1.31
Total Current Assets	336.09	435.92	660.93	275.3	425.77	346.95
Property, Plant & Equipment	134.63	128.5	105.05	95.65	58.42	52.32
Other Intangible Assets	18.53	19.81	12.37	-	-	0.07
Long-Term Deferred Tax Assets	2.79	3.56	3.24	3.06	2.08	1.83
Other Long-Term Assets	1.18	1.28	1.13	1.36	4.01	4.4
Total Assets	493.23	589.07	782.73	375.38	490.27	405.56

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.37	3.08	1.97	0.1	0.53	0.43
Accrued Expenses	46.27	53.76	51.8	39.05	40.4	23.51
Current Portion of Leases	5.79	4.57	3	5.05	5.04	4.45
Other Current Liabilities	2.46	12.03	3.98	0.53	0.39	0.16
Total Current Liabilities	68.79	73.44	60.74	44.74	46.37	28.55
Long-Term Debt	271.4	270.2	244.6	170.9	125.9	47.02
Long-Term Leases	77.72	66.82	49.63	47.91	19.22	16.55
Other Long-Term Liabilities	0.47	0.48	0.43	0.36	0.12	0.13
Total Liabilities	418.39	410.94	355.4	263.91	191.6	92.24

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,578	1,570	1,556	1,019	1,008	843.11
Retained Earnings	-1,497	-1,387	-1,099	-878.56	-670.18	-521.34
Comprehensive Income & Other	-5.98	-5.24	-29.06	-28.87	-38.78	-8.45
Shareholders' Equity	74.84	178.13	427.33	111.47	298.67	313.32
Total Liabilities & Equity	493.23	589.07	782.73	375.38	490.27	405.56

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	367.81	341.59	297.23	223.87	150.16	68.01
Net Cash (Debt)	-166.18	-40.88	290.79	15.7	232.28	242.32
Net Cash Growth	-	-	1752.19%	-93.24%	-4.15%	144.43%
Net Cash Per Share	-0.62	-0.15	1.14	0.09	2.45	3.36
Filing Date Shares Outstanding	266.16	266.14	266.13	265.93	173.07	90.91
Total Common Shares Outstanding	266.15	266.14	266.12	174.1	173.07	90.91
Working Capital	267.3	362.48	600.19	230.57	379.41	318.4
Book Value Per Share	0.28	0.67	1.61	0.64	1.73	3.45
Tangible Book Value	56.31	158.32	414.95	111.47	298.67	313.26
Tangible Book Value Per Share	0.21	0.59	1.56	0.64	1.73	3.45
Machinery	64.08	65.12	50.42	38.37	35.98	38.92
Construction In Progress	12.06	27.08	19.64	12.54	13.19	2.44
Leasehold Improvements	32.2	15.76	14.12	12.73	11.69	14.9

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error